Patents by Inventor Abdulkader RAHMO

Abdulkader RAHMO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250109385
    Abstract: Disclosed herein are small mobile stem (SMS) cells and methods of culturing, isolating, and using SMS cells.
    Type: Application
    Filed: October 15, 2024
    Publication date: April 3, 2025
    Inventor: Abdulkader Rahmo
  • Patent number: 12146164
    Abstract: Disclosed herein are small mobile stem (SMS) cells and methods of culturing, isolating, and using SMS cells. Also disclosed are methods of culturing SMS cells in an undifferentiated state for prolonged periods of time, and for using SMS cells for the production of a variety of molecules, including proteins, extracellular matrix (ECM) proteins, and the use of SMS cells in microfluidic devices.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: November 19, 2024
    Assignee: SMSbiotech, Inc.
    Inventor: Abdulkader Rahmo
  • Publication number: 20240301348
    Abstract: The presently disclosed subject matter relates, in general, to the identification, isolation, and use of a population of stem cells isolated from umbilical cord blood, peripheral blood, and/or other sources that are referred to herein as Small Mobile Stem cells (short: SMS). More particularly, the presently disclosed subject matter relates to isolating said SMS stem cells and employing the same, optionally after in vitro manipulation, to treat tissue and/or organ damage in a subject in need thereof.
    Type: Application
    Filed: March 15, 2024
    Publication date: September 12, 2024
    Inventor: Abdulkader Rahmo
  • Publication number: 20230117048
    Abstract: Disclosed herein are compositions for use in promoting or improving repair or regeneration of damaged tissue or for improving recovery from a viral, bacterial or fungal infection. The compositions include small mobile stem (SMS) cells. Also disclosed are methods of making the compositions, and methods of using the compositions for treating or ameliorating inflammatory illnesses, such as fibrosis or COPD, and/or a viral, bacterial or fungal infection or the damage caused by such pathogens.
    Type: Application
    Filed: February 24, 2021
    Publication date: April 20, 2023
    Inventor: Abdulkader Rahmo
  • Publication number: 20230002725
    Abstract: The presently disclosed subject matter relates, in general, to the identification, isolation, and use of a population of stem cells isolated from umbilical cord blood, peripheral blood, and/or other sources that are referred to herein as Small Mobile Stem cells (short: SMS). More particularly, the presently disclosed subject matter relates to isolating said SMS stem cells and employing the same, optionally after in vitro manipulation, to treat tissue and/or organ damage in a subject in need thereof.
    Type: Application
    Filed: May 6, 2022
    Publication date: January 5, 2023
    Inventor: Abdulkader Rahmo
  • Publication number: 20220364039
    Abstract: Disclosed herein are methods of inducing endothelial cell reorganization or differentiation to form micro- and macrovessel structures using an extracellular matrix, such as one derived from small mobile stem (SMS) cells, and a substrate, which can also be coated in molecules or otherwise physically manipulated to cause localized effects on reorganization Also disclosed is a kit implementation for performing endothelial cell reorganization.
    Type: Application
    Filed: September 29, 2020
    Publication date: November 17, 2022
    Inventor: Abdulkader Rahmo
  • Patent number: 11345886
    Abstract: The presently disclosed subject matter relates, in general, to the identification, isolation, and use of a population of stem cells isolated from umbilical cord blood, peripheral blood and/or other sources and that are referred to herein as Small Mobile Stem cells (short: SMS). More particularly, the presently disclosed subject matter relates to isolating said SMS stem cells and employing the same, optionally after in vitro manipulation, to treat tissue and/or organ damage in a subject in need thereof.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: May 31, 2022
    Assignee: SMSBIOTECH, INC.
    Inventor: Abdulkader Rahmo
  • Publication number: 20220002360
    Abstract: Disclosed herein are compositions comprising extracellular matrix proteins produced by small mobile stem cells, and systems comprising the composition. Also disclosed are methods of making the compositions and systems, and methods of using the compositions for treating or ameliorating a wound, such as a diabetic ulcer, a venous ulcer, a chronic ulcer, or a pressure ulcer, in a subject.
    Type: Application
    Filed: September 11, 2019
    Publication date: January 6, 2022
    Inventor: Abdulkader Rahmo
  • Publication number: 20200299649
    Abstract: Disclosed herein are small mobile stem (SMS) cells and methods of culturing, isolating, and using SMS cells. Also disclosed are methods of culturing SMS cells in an undifferentiated state for prolonged periods of time, and for using SMS cells for the production of a variety of molecules, including proteins, extracellular matrix (ECM) proteins, and the use of SMS cells in microfluidic devices.
    Type: Application
    Filed: March 27, 2017
    Publication date: September 24, 2020
    Inventor: Abdulkader Rahmo
  • Publication number: 20190010448
    Abstract: The presently disclosed subject matter relates, in general, to the identification, isolation, and use of a population of stem cells isolated from umbilical cord blood, peripheral blood and/or other sources and that are referred to herein as Small Mobile Stem cells (short: SMS). More particularly, the presently disclosed subject matter relates to isolating said SMS stem cells and employing the same, optionally after in vitro manipulation, to treat tissue and/or organ damage in a subject in need thereof.
    Type: Application
    Filed: July 18, 2018
    Publication date: January 10, 2019
    Inventor: Abdulkader Rahmo
  • Patent number: 10041037
    Abstract: The presently disclosed subject matter relates, in general, to the identification, isolation, and use of a population of stem cells isolated from umbilical cord blood, peripheral blood and/or other sources and that are referred to herein as Small Mobile Stem cells (short: SMS). More particularly, the presently disclosed subject matter relates to isolating said SMS stem cells and employing the same, optionally after in vitro manipulation, to treat tissue and/or organ damage in a subject in need thereof.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: August 7, 2018
    Assignee: SMSBIOTECH, INC.
    Inventor: Abdulkader Rahmo
  • Publication number: 20160122708
    Abstract: The presently disclosed subject matter relates, in general, to the identification, isolation, and use of a population of stem cells isolated from umbilical cord blood, peripheral blood and/or other sources and that are referred to herein as Small Mobile Stem cells (short: SMS). More particularly, the presently disclosed subject matter relates to isolating said SMS stem cells and employing the same, optionally after in vitro manipulation, to treat tissue and/or organ damage in a subject in need thereof.
    Type: Application
    Filed: June 9, 2014
    Publication date: May 5, 2016
    Inventor: Abdulkader RAHMO